156 related articles for article (PubMed ID: 37654668)
1. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort.
Gentilotti E; Górska A; Tami A; Gusinow R; Mirandola M; Rodríguez Baño J; Palacios Baena ZR; Rossi E; Hasenauer J; Lopes-Rafegas I; Righi E; Caroccia N; Cataudella S; Pasquini Z; Osmo T; Del Piccolo L; Savoldi A; Kumar-Singh S; Mazzaferri F; Caponcello MG; de Boer G; Hara GL; ; De Nardo P; Malhotra S; Canziani LM; Ghosn J; Florence AM; Lafhej N; van der Gun BTF; Giannella M; Laouénan C; Tacconelli E
EClinicalMedicine; 2023 Aug; 62():102107. PubMed ID: 37654668
[TBL] [Abstract][Full Text] [Related]
2. 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.
Augustin M; Stecher M; Wüstenberg H; Di Cristanziano V; Sandaradura de Silva U; Picard LK; Pracht E; Rauschning D; Gruell H; Klein F; Wenisch C; Hallek M; Schommers P; Lehmann C
Front Immunol; 2023; 14():1226622. PubMed ID: 37781408
[TBL] [Abstract][Full Text] [Related]
3. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study.
Bahmer T; Borzikowsky C; Lieb W; Horn A; Krist L; Fricke J; Scheibenbogen C; Rabe KF; Maetzler W; Maetzler C; Laudien M; Frank D; Ballhausen S; Hermes A; Miljukov O; Haeusler KG; Mokhtari NEE; Witzenrath M; Vehreschild JJ; Krefting D; Pape D; Montellano FA; Kohls M; Morbach C; Störk S; Reese JP; Keil T; Heuschmann P; Krawczak M; Schreiber S;
EClinicalMedicine; 2022 Sep; 51():101549. PubMed ID: 35875815
[TBL] [Abstract][Full Text] [Related]
4. Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
Legler F; Meyer-Arndt L; Mödl L; Kedor C; Freitag H; Stein E; Hoppmann U; Rust R; Wittke K; Siebert N; Behrens J; Thiel A; Konietschke F; Paul F; Scheibenbogen C; Bellmann-Strobl J
EClinicalMedicine; 2023 Sep; 63():102146. PubMed ID: 37662515
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
6. Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients.
Román-Montes CM; Flores-Soto Y; Guaracha-Basañez GA; Tamez-Torres KM; Sifuentes-Osornio J; González-Lara MF; de León AP
Front Public Health; 2023; 11():1155951. PubMed ID: 37255755
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
10. Post-COVID-19 syndrome symptoms after mild and moderate SARS-CoV-2 infection.
Al-Husinat L; Nusir M; Al-Gharaibeh H; Alomari AA; Smadi MM; Battaglini D; Pelosi P
Front Med (Lausanne); 2022; 9():1017257. PubMed ID: 36262270
[TBL] [Abstract][Full Text] [Related]
11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal course and predictors of health-related quality of life, mental health, and fatigue, in non-hospitalized individuals with or without post COVID-19 syndrome.
Kirchberger I; Meisinger C; Warm TD; Hyhlik-Dürr A; Linseisen J; Goßlau Y
Health Qual Life Outcomes; 2024 Apr; 22(1):32. PubMed ID: 38616282
[TBL] [Abstract][Full Text] [Related]
13. Long COVID exhibits clinically distinct phenotypes at 3-6 months post-SARS-CoV-2 infection: results from the P4O2 consortium.
Blankestijn JM; Abdel-Aziz MI; Baalbaki N; Bazdar S; Beekers I; Beijers RJHCG; Bloemsma LD; Cornelissen MEB; Gach D; Houweling L; Holverda S; Jacobs JJL; Jonker R; van der Lee I; Linders PMA; Mohamed Hoesein FAA; Noij LCE; Nossent EJ; van de Pol MA; Schaminee DW; Schols AMWJ; Schuurman LT; Sondermeijer B; Geelhoed JJM; van den Bergh JP; Weersink EJM; de Wit-van Wijck Y; Maitland-van der Zee AH;
BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38663887
[TBL] [Abstract][Full Text] [Related]
14. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON).
Appel KS; Nürnberger C; Bahmer T; Förster C; Polidori MC; Kohls M; Kraus T; Hettich-Damm N; Petersen J; Blaschke S; Bröhl I; Butzmann J; Dashti H; Deckert J; Dreher M; Fiedler K; Finke C; Geisler R; Hanses F; Hopff SM; Jensen BO; Konik M; Lehnert K; de Miranda SMN; Mitrov L; Miljukov O; Reese JP; Rohde G; Scherer M; Tausche K; Tebbe JJ; Vehreschild JJ; Voit F; Wagner P; Weigl M; Lemhöfer C;
Infection; 2024 Apr; ():. PubMed ID: 38587752
[TBL] [Abstract][Full Text] [Related]
15. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.
Augustin M; Schommers P; Stecher M; Dewald F; Gieselmann L; Gruell H; Horn C; Vanshylla K; Cristanziano VD; Osebold L; Roventa M; Riaz T; Tschernoster N; Altmueller J; Rose L; Salomon S; Priesner V; Luers JC; Albus C; Rosenkranz S; Gathof B; Fätkenheuer G; Hallek M; Klein F; Suárez I; Lehmann C
Lancet Reg Health Eur; 2021 Jul; 6():100122. PubMed ID: 34027514
[TBL] [Abstract][Full Text] [Related]
16. Long-term health consequences of COVID-19 in survivors hospitalised at a tertiary care hospital and their correlation with acute COVID-19 severity and associated risk factors.
Jain V; Nabi N; Aggarwal S; Alam Z; Chandra K; Singh D; Kashyap V; Islam F; Kohli S
J Clin Nurs; 2024 Jan; 33(1):115-125. PubMed ID: 36802108
[TBL] [Abstract][Full Text] [Related]
17. Post-COVID syndrome. A case series and comprehensive review.
Anaya JM; Rojas M; Salinas ML; Rodríguez Y; Roa G; Lozano M; Rodríguez-Jiménez M; Montoya N; Zapata E; ; Monsalve DM; Acosta-Ampudia Y; Ramírez-Santana C
Autoimmun Rev; 2021 Nov; 20(11):102947. PubMed ID: 34509649
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke M; Freitag H; Rudolf G; Seifert M; Doehner W; Scherbakov N; Hanitsch L; Wittke K; Bauer S; Konietschke F; Paul F; Bellmann-Strobl J; Kedor C; Scheibenbogen C; Sotzny F
J Transl Med; 2022 Mar; 20(1):138. PubMed ID: 35317812
[TBL] [Abstract][Full Text] [Related]
19. Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern.
Mazzaferri F; Mirandola M; Savoldi A; De Nardo P; Morra M; Tebon M; Armellini M; De Luca G; Calandrino L; Sasset L; D'Elia D; Sozio E; Danese E; Gibellini D; Monne I; Scroccaro G; Magrini N; Cattelan A; Tascini C; ; Tacconelli E
Elife; 2022 Nov; 11():. PubMed ID: 36413383
[TBL] [Abstract][Full Text] [Related]
20. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation.
Kuchler T; Günthner R; Ribeiro A; Hausinger R; Streese L; Wöhnl A; Kesseler V; Negele J; Assali T; Carbajo-Lozoya J; Lech M; Schneider H; Adorjan K; Stubbe HC; Hanssen H; Kotilar K; Haller B; Heemann U; Schmaderer C
Angiogenesis; 2023 Nov; 26(4):547-563. PubMed ID: 37507580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
